Literature DB >> 21553347

Activated immune cells in Parkinson's disease.

Jun-Jun Cao1, Kang-Sheng Li, Yan-Qin Shen.   

Abstract

Recently, an interaction between neurodegenerative processes and the innate and adaptive immune responses has been increasingly recognized. Activation of microglia, infiltration of peripheral T lymphocytes, and T-cell interaction with microglia may strongly affect the progression of Parkinson's disease (PD) both in patients and in animal models of the disease. Here, we summarize the current knowledge regarding the role of microglia in the progression of PD. The plasticity of the microglial response is also discussed in the context of PD. In addition, we also focus on the influence of several peripheral T-cell subsets on PD progression as well as on possible pathways by which they might act. This review should help increase our understanding of the effects of innate and adaptive immune cells in the pathogenesis of PD.

Entities:  

Mesh:

Year:  2011        PMID: 21553347     DOI: 10.1007/s11481-011-9280-9

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  49 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Alterations of T-lymphocyte populations in Parkinson disease.

Authors:  Yasuhiko Baba; Ataru Kuroiwa; Ryan J Uitti; Zbigniew K Wszolek; Tatsuo Yamada
Journal:  Parkinsonism Relat Disord       Date:  2005-09-09       Impact factor: 4.891

3.  Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells.

Authors:  K McQuillan; Marina A Lynch; Kingston H G Mills
Journal:  Brain Behav Immun       Date:  2010-01-12       Impact factor: 7.217

4.  Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism.

Authors:  J Bas; M Calopa; M Mestre; D G Molleví; B Cutillas; S Ambrosio; E Buendia
Journal:  J Neuroimmunol       Date:  2001-02-01       Impact factor: 3.478

5.  MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease.

Authors:  I Kurkowska-Jastrzebska; A Wrońska; M Kohutnicka; A Członkowski; A Członkowska
Journal:  Acta Neurobiol Exp (Wars)       Date:  1999       Impact factor: 1.579

6.  Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.

Authors:  Ana Laura De Lella Ezcurra; Mariela Chertoff; Carina Ferrari; Mariana Graciarena; Fernando Pitossi
Journal:  Neurobiol Dis       Date:  2009-12-05       Impact factor: 5.996

7.  Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.

Authors:  Krishnan Sriram; Joanna M Matheson; Stanley A Benkovic; Diane B Miller; Michael I Luster; James P O'Callaghan
Journal:  FASEB J       Date:  2002-07-18       Impact factor: 5.191

8.  Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

Authors:  G Boka; P Anglade; D Wallach; F Javoy-Agid; Y Agid; E C Hirsch
Journal:  Neurosci Lett       Date:  1994-05-19       Impact factor: 3.046

9.  Rate of cell death in parkinsonism indicates active neuropathological process.

Authors:  P L McGeer; S Itagaki; H Akiyama; E G McGeer
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

10.  Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.

Authors:  Eric J Benner; Rebecca Banerjee; Ashley D Reynolds; Simon Sherman; Vladimir M Pisarev; Vladislav Tsiperson; Craig Nemachek; Pawel Ciborowski; Serge Przedborski; R Lee Mosley; Howard E Gendelman
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

View more
  10 in total

1.  Peripheral Blood Monocyte Tolerance Alleviates Intraperitoneal Lipopolysaccharides-Induced Neuroinflammation in Rats Via Upregulating the CD200R Expression.

Authors:  Liping Xia; Xin Xie; Yang Liu; Xiaoguang Luo
Journal:  Neurochem Res       Date:  2017-06-29       Impact factor: 3.996

2.  Innate and adaptive immune responses in neurodegeneration and repair.

Authors:  Sandra Amor; M Nicola Woodroofe
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

3.  Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia.

Authors:  Christopher J Gibson; Muhammad M Hossain; Jason R Richardson; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2012-08-31       Impact factor: 4.030

4.  Converging mediators from immune and trophic pathways to identify Parkinson disease dementia.

Authors:  Lih-Fen Lue; Christopher T Schmitz; Noelle L Snyder; Kewei Chen; Douglas G Walker; Kathryn J Davis; Christine Belden; John N Caviness; Erika Driver-Dunckley; Charles H Adler; Marwan N Sabbagh; Holly A Shill
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-01-27

5.  Immune Profiling of Parkinson's Disease Revealed Its Association With a Subset of Infiltrating Cells and Signature Genes.

Authors:  Xi Zhang; Zhihua Shao; Sutong Xu; Qiulu Liu; Chenming Liu; Yuping Luo; Lingjing Jin; Siguang Li
Journal:  Front Aging Neurosci       Date:  2021-02-09       Impact factor: 5.750

Review 6.  Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.

Authors:  Shelby Loraine Hatton; Manoj Kumar Pandey
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

7.  Ganoderma lucidum Modulates Inflammatory Responses following 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice.

Authors:  Zhili Ren; Hui Ding; Ming Zhou; Piu Chan
Journal:  Nutrients       Date:  2022-09-19       Impact factor: 6.706

Review 8.  MPTP-induced mouse model of Parkinson's disease: A promising direction of therapeutic strategies.

Authors:  Musa Mustapha; Che Norma Mat Taib
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

Review 9.  Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.

Authors:  Sandeep Vasant More; Hemant Kumar; In Su Kim; Soo-Yeol Song; Dong-Kug Choi
Journal:  Mediators Inflamm       Date:  2013-06-27       Impact factor: 4.711

10.  Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance.

Authors:  Ming Lu; Cunjin Su; Chen Qiao; Yaqi Bian; Jianhua Ding; Gang Hu
Journal:  Int J Neuropsychopharmacol       Date:  2016-09-21       Impact factor: 5.176

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.